The exploitation of natural killer (NK) cell-mediated antileukemic responses in its various facets (emergence of alloreactive NK cells early posttransplantation, cotransfer of mature NK cells during graft manipulation, and adoptive transfer of mature NK cells) has recently come into the focus (reviewed by Handgretinger et al 1 ). Recent publications indicate that NK cells-although belonging per definition to the innate immune system-may acquire under certain conditions (such as high concentrations of cytokines or viral and presumably also tumor antigens) features of adaptive immune cells. 2 Depending on the initiating stimulus, we distinguish these memory NK cells as cytomegalovirus-induced, cytokine-induced, or tumor-induced memory NK cells. Theoretically, these memory NK cells should entail a higher clinical efficacy 1 as they are long-lived, vividly expand, Abstract Natural killer (NK) cells belong to innate lymphoid immune cells that contribute to antitumor responses without requiring prior sensitization. There is strong evidence that NK cells may induce graft-vs-leukemia (GvL) effect without causing graft-vs-host disease (GvHD), and significant efforts are currently undertaken to design and optimize NK cell-based immunotherapeutic strategies against human cancers, particularly against leukemias. However, the results of a number of adoptive NK cell transfer How to cite this article: Schmidt M, André MC. From bench to bedside: Exploiting memory NK cell responses to leukemia.Adv Cell Gene Ther. 2019;2:e28. https://doi.